NEFL and Parkinson disease: Lastly, the absence of an observed association between blood EV NfL and other common PD biomarkers, particularly α-synuclein, along with the limited availability of animal studies to confirm the correlation between blood EV NfL and PD pathology, weakens the evidence supporting the relevance of blood EV NfL to the underlying pathology of PD.